|
KIAA1609 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.64013247427874E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.19744231092045E-14 |
| Normal-vs-Stage2 |
7.28719999898431E-08 |
| Normal-vs-Stage3 |
9.65519999507336E-08 |
| Normal-vs-Stage4 |
3.6161074135066E-12 |
| Stage1-vs-Stage2 |
9.958400E-01 |
| Stage1-vs-Stage3 |
9.424800E-01 |
| Stage1-vs-Stage4 |
1.278380E-02 |
| Stage2-vs-Stage3 |
9.532000E-01 |
| Stage2-vs-Stage4 |
5.321700E-02 |
| Stage3-vs-Stage4 |
5.504100E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.76647585448109E-12 |
| Normal-vs-AfricanAmerican |
1.34320000011456E-07 |
| Normal-vs-Asian |
2.24220000000219E-06 |
| Caucasian-vs-AfricanAmerican |
2.703800E-01 |
| Caucasian-vs-Asian |
2.763600E-01 |
| AfricanAmerican-vs-Asian |
9.304500E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.7715611723761E-16 |
| Normal-vs-Female |
7.58615392726369E-12 |
| Male-vs-Female |
1.491800E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.74470438096819E-11 |
| Normal-vs-Age(41-60Yrs) |
3.33955085807247E-13 |
| Normal-vs-Age(61-80Yrs) |
3.489500022269E-09 |
| Normal-vs-Age(81-100Yrs) |
1.626400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.566400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.359800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.318800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.791600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.824400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.342000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.049400E-01 |
| Classical-VS-Follicular |
2.082000E-03 |
| Classical-VS-Other |
2.475400E-01 |
| Classical-VS-Normal |
1.87383442096234E-12 |
| Tall-VS-Follicular |
1.202360E-01 |
| Tall-VS-Other |
3.915400E-01 |
| Tall-VS-Normal |
1.007900E-02 |
| Follicular-VS-Other |
9.075000E-01 |
| Follicular-VS-Normal |
1.7054135881267E-12 |
| Other-VS-Normal |
6.774900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.22124532708767E-15 |
| Normal-vs-N1 |
1.33659971979228E-10 |
| N0-vs-N1 |
1.882410E-01 |
|
|
